Molecular Classification
Receptor-associated protein complex, Immunoglobulin superfamily (individual chains), Signal transduction molecule
Other Names
Cluster of differentiation 3, T3 complex, CD3 complex, T cell co-receptor, TCR-CD3 complex (when referring to the full signaling unit with the T cell receptor)
Disease Roles
Cancer (targeted in immunotherapy, e.g., bispecific antibodies)Infection (role in immune defense)Immune system diseases/autoimmunity

CD3 antigen complex Overview

The **CD3 antigen complex** is a multimeric protein assembly found exclusively on the surface of mature **T lymphocytes**. It consists of four distinct polypeptide chains—CD3γ, CD3δ, two copies of CD3ε—and usually associates with a homodimeric zeta chain (CD247), forming three pairs of dimers within the larger **T-cell receptor–CD3 (TCR–CD3) signaling apparatus**. The primary function is as a signal-transducing module for the antigen-specific αβ or γδ **T-cell receptor**, which itself lacks intrinsic signaling capacity. Upon engagement by peptide-MHC complexes presented by antigen-presenting cells, conformational changes and phosphorylation events within conserved intracellular ITAM motifs on each chain initiate downstream signaling cascades that drive **T-cell activation**, proliferation, cytokine production, and effector functions essential for adaptive immunity. The presence and integrity of all subunits are required for proper assembly at the plasma membrane; loss or mutation leads to severe immunodeficiency due to failed surface expression and function. The unique expression pattern makes it an ideal pan-T cell marker in diagnostics as well as a key therapeutic target—most notably exploited by monoclonal antibodies such as muromonab-CD3 for transplant rejection prevention and bispecific antibody constructs like blinatumomab in oncology. Therapeutic manipulation carries significant risks including cytokine release syndrome from rapid systemic immune activation. Research continues into more selective targeting strategies leveraging its central role in adaptive immunity.[1][4][5][6]

Mechanism of Action

Antibody-mediated modulation or depletion of T cells via binding to CD3ε subunit, leading to immune activation or suppression depending on context

Biological Functions

Immune response
Signal transduction
T cell activation
Antigen recognition (as part of the TCR-CD3 complex)

Disease Associations

Cancer (targeted in immunotherapy, e.g., bispecific antibodies)
Infection (role in immune defense)
Immune system diseases/autoimmunity

Safety Considerations

  • Cytokine release syndrome with therapeutic anti-CD3 antibodies due to massive immune activation
  • Risk of immunosuppression/infection when depleting or modulating all mature T cells via this target

Interacting Drugs

Muromonab-CD3 (OKT3, anti-CD3 monoclonal antibody)
Blinatumomab and other bispecific antibodies targeting CD19/CD3 or similar constructs for cancer immunotherapy

Associated Biomarkers

Biomarker
Pan-T cell marker for flow cytometry and histology; used to identify and quantify total mature T cells in blood/tissue samples